
doi: 10.1007/bf03351409
pmid: 15810202
Of the future technologies arising from the Human Genome Project, pharmacogenomics will probably be the first to have a widespread impact on the everyday practice of medicine. This technology offers great benefits but also presents some difficult ethical challenges. This paper explains what pharmacogenomics is and examines three of the issues that it raises: orphan populations, the use of ethnicity in drug trials, and potential obstacles to informed consent for genetic testing.
Clinical Trials as Topic, Genetic Research, Informed Consent, Research Subjects, Racial Groups, Resource Allocation, Rare Diseases, Pharmacogenetics, Social Justice, Humans, Genetic Testing
Clinical Trials as Topic, Genetic Research, Informed Consent, Research Subjects, Racial Groups, Resource Allocation, Rare Diseases, Pharmacogenetics, Social Justice, Humans, Genetic Testing
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 8 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
